ArticleVaccines2023

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).

Alexander B Ryzhikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.